Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02168088

Molecular Autopsy Study

Molecular Autopsy for Sudden Cardiovascular Death

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Scripps Translational Science Institute · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.

Detailed description

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death, initially in San Diego County with plans to expand nationally and internationally as funding allows. Genetic testing of the index subjects and their parents (or other biological family members if parents are not available) will be assessed for potential heritable causes of sudden death. By combining the wide catchment base of the San Diego Medical Examiner's Office, sequencing expertise of SD-based collaborators, computing power of the San Diego Supercomputer Center and in-house and external genomic analytics, the Scripps Translational Science Institute aims to provide a more complete characterization and understanding of the genetic causes of sudden death. Ultimately, findings from this study will be utilized to identify previously unrecognized mechanism of sudden death allowing for the development of preventative screening programs and potentially life-saving interventions.

Conditions

Timeline

Start date
2014-06-01
Primary completion
2025-06-01
Completion
2030-06-01
First posted
2014-06-20
Last updated
2025-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02168088. Inclusion in this directory is not an endorsement.

Molecular Autopsy Study (NCT02168088) · Clinical Trials Directory